Company Poniard Pharmaceuticals, Inc.

Equities

PARD

US7324494001

Pharmaceuticals

Market Closed - OTC Markets 03:13:39 2024-03-26 pm EDT 5-day change 1st Jan Change
0.0001 USD -0.99% Intraday chart for Poniard Pharmaceuticals, Inc. -.--% -.--%

Business Summary

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.

Number of employees: 8

Sales per Business

USD in Million2009Weight2010Weight Delta
Cancer Therapeutics
nan %
0 nan % 0 nan % +-NaN%

Sales per region

USD in Million2009Weight2010Weight Delta
United States
nan %
0 nan % 0 nan % +-NaN%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,499,232 37,481 ( 2.500 %) 0 2.500 %
Stock B 0 78,768 0 0

Shareholders

NameEquities%Valuation
Oppenheim Fonds Trust GmbH
0.0139 %
208 0.0139 % - $
AlphaStream Portfolios, Inc.
0.000934 %
14 0.000934 % - $

Company contact information

Poniard Pharmaceuticals, Inc.

300 Elliott Avenue West Suite 530

98119, Seattle

+

address Poniard Pharmaceuticals, Inc.(PARD)
  1. Stock Market
  2. Equities
  3. PARD Stock
  4. Company Poniard Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW